Fosun International LTD Kura Oncology, Inc. Transaction History

Fosun International LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$14.75 - $20.87 $5.47 Million - $7.74 Million	-370,958 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$14.71 - $19.79 $956,150 - $1.29 Million	65,000 Added 21.24%	370,958 $7.34 Million
Q1 2019 May 10, 2019	BUY	$13.73 - $16.87 $1.4 Million - $1.72 Million	101,724 Added 49.81%	305,958 $4.97 Million
Q4 2018 Jan 31, 2019	BUY	$10.6 - $17.49 $2.16 Million - $3.57 Million	204,234 New	204,234 $2.64 Million

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $668M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.